CAS 2035008-70-7

Levilimab

CAS : 2035008-70-7

Levilimab (BCD-089) is a fully humanized human monoclonal antibody targeting membrane-bound and soluble IL-6 R for the study of rheumatoid arthritis.

Degré de pureté : 97.8% (SDS-PAGE); 97.3% (SEC-HPLC) - 97.8% (SDS-PAGE); 97.3% (SEC-HPLC)

Couleur et forme : Transparent Liquid

Masse moléculaire : 145.69 kDa (Predicted)

Ref: TM-T77062

Levilimab

CAS : 2035008-70-7

Degré de pureté : 95%

Ref: IN-DA02EOBW